418
Views
27
CrossRef citations to date
0
Altmetric
EPIDEMIOLOGY

The predictors of survival in Chinese amyotrophic lateral sclerosis patients

, , , , , , & show all
Pages 237-244 | Received 20 Aug 2014, Accepted 26 Nov 2014, Published online: 12 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Elisa Bianchi, Elisabetta Pupillo, Antonio De Feudis, Gabriele Enia, Eugenio Vitelli & Ettore Beghi. (2022) Trends in survival of ALS from a population-based registry. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 344-352.
Read now
Zhengyi Cai, Qing Liu, Mingsheng Liu, Xunzhe Yang, Dongchao Shen, Xiaohan Sun, Di He, Kang Zhang, Liang Shang, Xue Zhang & Liying Cui. (2022) Survival analysis of clinical and genetic factors in an amyotrophic lateral sclerosis cohort from China. Neurological Research 44:7, pages 651-658.
Read now
Jiao Liu, Xiaoyue Luo, Xueping Chen & Huifang Shang. (2020) Serum creatinine levels in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 502-508.
Read now
Pamela A. McCombe, Fleur C Garton, Matthew Katz, Naomi R Wray & Robert D Henderson. (2020) What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?. Expert Review of Neurotherapeutics 20:9, pages 921-941.
Read now

Articles from other publishers (23)

Yahui Zhu, Jiongming Bai, Mao Li, Hongfen Wang, Jiao Wang & Xusheng Huang. (2023) Repetitive nerve stimulation on survival in amyotrophic lateral sclerosis. Frontiers in Neurology 14.
Crossref
Yahui Zhu, Yunyun Huo, Jiongming Bai, Mao Li, Hongfen Wang, Jiao Wang & Xusheng Huang. (2023) Serum Cystatin C is a potential biomarker for predicting amyotrophic lateral sclerosis survival. Neurological Sciences.
Crossref
Baoyi Huang, Xiang Geng, Zhiyin Yu, Chengfeng Zhang & Zheng Chen. (2023) Dynamic effects of prognostic factors and individual survival prediction for amyotrophic lateral sclerosis disease. Annals of Clinical and Translational Neurology 10:6, pages 892-903.
Crossref
Jin-Yue Li, Xiao-Han Sun, Zheng-Yi Cai, Dong-chao Shen, Xun-Zhe Yang, Ming-Sheng Liu & Li-Ying Cui. (2022) Correlation of weight and body composition with disease progression rate in patients with amyotrophic lateral sclerosis. Scientific Reports 12:1.
Crossref
Jinyue Li, Qing Liu, Xiaohan Sun, Kang Zhang, Shuangwu Liu, Zhili Wang, Xunzhe Yang, Mingsheng Liu, Liying Cui & Xue Zhang. (2022) Genotype–phenotype association of TARDBP mutations in Chinese patients with amyotrophic lateral sclerosis: a single-center study and systematic review of published literature. Journal of Neurology 269:8, pages 4204-4212.
Crossref
Jin-Yue Li, Xiao-Han Sun, Dong-chao Shen, Xun-Zhe Yang, Ming-Sheng Liu & Li-Ying Cui. (2022) Clinical characteristics and prognosis of amyotrophic lateral sclerosis with autoimmune diseases. PLOS ONE 17:4, pages e0266529.
Crossref
Robert J. Nona, Zhouwei Xu, Gail A. Robinson, Robert D. Henderson & Pamela A. McCombe. (2022) Age of Onset and Length of Survival of Queensland Patients with Amyotrophic Lateral Sclerosis: Details of Subjects with Early Onset and Subjects with Long Survival. Neurodegenerative Diseases 22:3-4, pages 104-121.
Crossref
Qian-Qian Wei, Yanbing Hou, Yongping Chen, Ruwei Ou, Bei Cao, Lingyu Zhang, Tianmi Yang & Huifang Shang. (2021) Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L. Health and Quality of Life Outcomes 19:1.
Crossref
Markus Engel, Christian Glatz, Cornelia Helmle, Peter Young, Bianca Dräger & Matthias Boentert. (2021) Respiratory parameters on diagnostic sleep studies predict survival in patients with amyotrophic lateral sclerosis. Journal of Neurology 268:11, pages 4321-4331.
Crossref
Ming Gao, Na Liu, Xue-Mei Li, Liu-Wen Chao, Hong-Qi LinYan Wang, Yan Sun, Chen Huang, Xiao-Gang Li & Min Deng. (2021) Epidemiology and factors predicting survival of amyotrophic lateral sclerosis in a large Chinese cohort. Chinese Medical Journal 134:18, pages 2231-2236.
Crossref
Filipe Emanuel Oliveira de Almeida, Anne Kelly do Carmo Santana & Fernanda Oliveira de Carvalho. (2021) Multidisciplinary care in Amyotrophic Lateral Sclerosis: a systematic review and meta-analysis. Neurological Sciences 42:3, pages 911-923.
Crossref
Qionghua Sun, Yunyun Huo, Jiongming Bai, Haoran Wang, Fang Cui, Hongfen Wang, Fei Yang & Xusheng Huang. (2021) Characteristics of Late-Onset Amyotrophic Lateral Sclerosis in a Chinese Cohort. Neurodegenerative Diseases 21:1-2, pages 24-29.
Crossref
Krzysztof Barć, Katarzyna Szacka, Krzysztof Nieporęcki, Mamede de Carvalho, Marta Gromicho, Julian Grosskreutz, Susanne Petri, Annekathrin Rödiger, Robert Steinbach, Hilmi Uysal & Magdalena Kuźma-Kozakiewicz. (2020) Emotional Lability at Disease Onset Is an Independent Prognostic Factor of Faster Disease Progression in Amyotrophic Lateral Sclerosis. Aging and disease 11:5, pages 1021.
Crossref
Tanxin Liu, Dongchao Shen, Xunzhe Yang, Bo Cui, Hongfei Tai, Zhili Wang, Shuangwu Liu, Kang Zhang, Mingsheng Liu & Liying Cui. (2019) Early onset but long survival and other prognostic factors in Chinese sporadic amyotrophic lateral sclerosis. Journal of Clinical Neuroscience 69, pages 74-80.
Crossref
Bei Cao, Qianqian Wei, Ruwei Ou, Lingyu Zhang, Yanbing Hou, Yongping Chen & Huifang Shang. (2019) Neurophysiological index is associated with the survival of patients with amyotrophic lateral sclerosis. Clinical Neurophysiology 130:9, pages 1730-1733.
Crossref
Sonja Korner, Johanna Kammeyer, Antonia Zapf, Magdalena Kuzma-Kozakiewicz, Maria Piotrkiewicz, Bożenna Kuraszkiewicz, Hanna Goszczynska, Marta Gromicho, Julian Grosskreutz, Peter M. Andersen, Mamede de Carvalho & Susanne Petri. (2019) Influence of Environment and Lifestyle on Incidence and Progress of Amyotrophic Lateral Sclerosis in A German ALS Population. Aging and disease 10:2, pages 205.
Crossref
Qian-Qian Wei, Yongping Chen, Xueping Chen, Bei Cao, RuWei Ou, Lingyu Zhang, Yanbing Hou & Huifang Shang. (2018) Clinical and prognostic features of ALS/MND in different phenotypes–data from a hospital-based registry. Brain Research Bulletin 142, pages 403-408.
Crossref
Xiaolu Liu, Ji He, Fen-Biao Gao, Aaron D. Gitler & Dongsheng Fan. (2018) The epidemiology and genetics of Amyotrophic lateral sclerosis in China. Brain Research 1693, pages 121-126.
Crossref
Xueping Chen, Qian-Qian Wei, Yongping Chen, Bei Cao, RuWei Ou, Yanbing Hou, Xiaoqin Yuan, Lingyu Zhang, Hui Liu & Huifang Shang. (2018) Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients. Frontiers in Neurology 9.
Crossref
Angela Rosenbohm, Mingsheng Liu, Gabriele Nagel, Raphael S. Peter, Bo Cui, Xiaoguang Li, Jan Kassubek, Dietrich Rothenbacher, Dorothée Lulé, Liying Cui & Albert C. Ludolph. (2018) Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany. Journal of Neurology 265:4, pages 774-782.
Crossref
Andrea Calvo, Cristina Moglia, Christian Lunetta, Kalliopi Marinou, Nicola Ticozzi, Gianluca Drago Ferrante, Carlo Scialo, Gianni Sorarù, Francesca Trojsi, Amelia Conte, Yuri M. Falzone, Rosanna Tortelli, Massimo Russo, Adriano Chiò, Valeria Ada Sansone, Gabriele Mora, Vincenzo Silani, Paolo Volanti, Claudia Caponnetto, Giorgia Querin, Maria Rosaria Monsurrò, Mario Sabatelli, Nilo Riva, Giancarlo Logroscino, Sonia Messina, Nicola Fini & Jessica Mandrioli. (2016) Factors predicting survival in ALS: a multicenter Italian study. Journal of Neurology 264:1, pages 54-63.
Crossref
N Shahrizaila, G Sobue, S Kuwabara, S H Kim, Carol Birks, D S Fan, J S Bae, C J Hu, M Gourie-Devi, Y Noto, K Shibuya, K J Goh, R Kaji, CP Tsai, L Cui, P Talman, R D Henderson, S Vucic & M C Kiernan. (2016) Amyotrophic lateral sclerosis and motor neuron syndromes in Asia. Journal of Neurology, Neurosurgery & Psychiatry 87:8, pages 821-830.
Crossref
Sabrina K. Hollinger, Ike S. Okosun & Cassie S. Mitchell. (2016) Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?. Frontiers in Neurology 7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.